RAGONESE, Marta
 Distribuzione geografica
Continente #
EU - Europa 3.306
NA - Nord America 3.097
AS - Asia 1.523
SA - Sud America 493
Continente sconosciuto - Info sul continente non disponibili 166
AF - Africa 54
OC - Oceania 2
Totale 8.641
Nazione #
US - Stati Uniti d'America 2.987
RU - Federazione Russa 1.862
SG - Singapore 608
CN - Cina 455
BR - Brasile 422
IE - Irlanda 306
IT - Italia 283
SE - Svezia 276
HK - Hong Kong 164
DE - Germania 128
GB - Regno Unito 102
FR - Francia 97
VN - Vietnam 77
PL - Polonia 72
FI - Finlandia 54
IN - India 46
CA - Canada 35
UA - Ucraina 34
BD - Bangladesh 29
AT - Austria 26
JP - Giappone 25
MX - Messico 25
AR - Argentina 24
IQ - Iraq 23
NL - Olanda 19
CO - Colombia 16
ID - Indonesia 15
TR - Turchia 15
ZA - Sudafrica 15
PK - Pakistan 11
ES - Italia 10
VE - Venezuela 10
JM - Giamaica 9
CR - Costa Rica 8
KE - Kenya 8
MA - Marocco 7
PE - Perù 7
UZ - Uzbekistan 7
BE - Belgio 6
EC - Ecuador 6
MY - Malesia 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
PH - Filippine 5
SV - El Salvador 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EE - Estonia 4
HN - Honduras 4
JO - Giordania 4
NI - Nicaragua 4
NP - Nepal 4
PR - Porto Rico 4
RS - Serbia 4
TN - Tunisia 4
AL - Albania 3
CW - ???statistics.table.value.countryCode.CW??? 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8.477
Città #
Ashburn 575
Moscow 483
Singapore 333
Dublin 305
Dallas 243
San Jose 220
Chandler 194
Nyköping 173
Hong Kong 161
Beijing 156
Messina 113
The Dalles 103
Council Bluffs 83
Jacksonville 75
Los Angeles 74
Warsaw 70
Munich 67
New York 65
Lauterbourg 47
Princeton 44
Medford 42
São Paulo 41
Lancaster 40
Dearborn 35
Cambridge 29
Des Moines 29
Santa Clara 27
Tianjin 27
Buffalo 24
Phoenix 23
Brooklyn 22
Orem 21
Boardman 19
Ho Chi Minh City 19
Tokyo 19
Vienna 19
Ann Arbor 18
Frankfurt am Main 18
Redondo Beach 18
Shenyang 18
Helsinki 17
Hanoi 15
London 14
Rome 14
Seattle 14
Columbus 12
Guangzhou 12
Rio de Janeiro 12
Wilmington 12
Baghdad 11
Catania 11
Jinan 11
Nanjing 11
Amsterdam 10
Atlanta 10
Belo Horizonte 10
Brasília 10
Denver 10
Houston 10
Hyderabad 10
Pune 10
Shenzhen 10
Chicago 9
Johannesburg 9
Mexico City 9
Toronto 9
Bogotá 8
Jakarta 8
Manchester 8
Montreal 8
Nairobi 8
Nanchang 8
San Mateo 8
Turku 8
Chennai 7
Düsseldorf 7
Milan 7
Naples 7
Nuremberg 7
Stockholm 7
Tashkent 7
Boston 6
Campinas 6
Curitiba 6
Dong Ket 6
Haikou 6
Hangzhou 6
Lappeenranta 6
Woodbridge 6
Biên Hòa 5
Changsha 5
Faisalabad 5
Hillsboro 5
Joinville 5
Kingston 5
Lima 5
Mumbai 5
Poplar 5
Randolph Township 5
San Francisco 5
Totale 4.600
Nome #
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 324
Effects of cyberknife radiotherapy treatment of pituitary adenomas 300
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 256
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 225
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 216
A case of clinically silent acromegaly with erectile dysfunction. 202
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 192
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 190
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 184
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 182
Increased prevalence of acromegaly in a highly polluted area. 182
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 178
Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women with Hashimoto's Thyroiditis 177
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 176
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 174
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 172
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 172
Course of pregnancies in women with Cushing's disease treated by gamma-knife 171
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 171
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 170
Predictive markers of recurrence in radically resected pituitary macroadenomas 166
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 166
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 163
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 162
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 160
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 158
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 157
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 157
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 157
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 156
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 154
Thyroid nodules in growth hormone replaced patients. 152
How to improve effectiveness of pegvisomant treatment in acromegalic patients 151
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 148
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 147
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 142
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 140
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 139
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 120
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 118
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 115
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 106
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 102
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 102
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 102
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 100
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 96
Valutazione della morfologia e funzionalità tiroidea in pazienti acromegalici 95
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 94
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 93
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 92
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 91
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 88
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 85
Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes 79
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients 42
null 35
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 32
null 27
Adverse hepato-biliary-pancreatic events in acromegaly patients treated with first generation somatostatin receptor ligands 18
Preconception body mass index and maternal thyroid function: a longitudinal observational study 10
Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control 10
Totale 8.641
Categoria #
all - tutte 27.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022242 0 0 0 13 7 5 9 17 3 52 38 98
2022/2023865 81 87 47 48 44 82 31 27 358 8 43 9
2023/2024292 20 44 15 28 29 70 9 29 0 13 2 33
2024/20251.403 21 32 57 83 99 43 47 276 293 98 132 222
2025/20264.234 224 241 282 252 362 917 514 559 548 179 74 82
2026/2027853 79 325 180 269 0 0 0 0 0 0 0 0
Totale 8.641